Algorithm for non-invasive risk stratification of individuals with suspected MASLD (reproduced with modifications from Tacke et al 1 under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/)). (IMAGE)

First Hospital of Jilin University

Algorithm for non-invasive risk stratification of individuals with suspected MASLD (reproduced with modifications from Tacke et al 1 under the CC BY-NC license (https://creativecommons.org/licenses/by-nc/4.0/)).

Caption

*FIB-4 cut-offs are valid for age≤65 years (for >65 years, the lower FIB-4 cut-off is 2.0). **For example, lifestyle interventions, treatment of comorbidities (eg, glucagon-like protein-1 receptor antagonist) and bariatric surgery. ***Alternative test, for example, magnetic resonance elastography (MRE), shear wave elastography (SWE) or enhanced liver fibrosis (ELF) test, with their respective cut-offs. Ⓐ and Ⓑ are options, depending on the disease course, clinical context and local resources. FIB-4, fibrosis-4 index; MASLD, metabolic dysfunction-associated steatotic liver disease; VCTE, vibration-controlled transient elastography.

Credit

By Paul Horn, Frank Tacke

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted.

License

CC BY-NC

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.